Company Overview and News

47
Castle Brands: Performance Remains Solid, Valuation Remains A Question Mark

2018-06-19 seekingalpha
Castle Brands posted a nice FY18, as growth in the core whiskey and ginger beer categories continues.
STZ.B VGR RCO REMYY STZ ROX REMYF

0
REFILE-UPDATE 1-Banks push European bourses higher as ECB speculation lifts yields

2018-06-07 reuters
LONDON, June 7 (Reuters) - European shares switched to risk-on mode on Thursday, joining an overnight rally on Wall Street and in Asia, with the banking sector posting the best performance amid expectations that the European Central Bank may soon start to wind down its stimulus.
RCO REMYY BNNCY REMYF

0
Banks push European bourses higher as ECB speculation lift yields

2018-06-07 thehindubusinessline
European shares switched to risk-on mode on Thursday, joining an overnight rally on Wall Street and in Asia, with the banking sector posting the best performance amid expectations that the European Central Bank may soon start to wind down its stimulus.
RCO REMYY BNNCY REMYF

0
Banks push European bourses higher as ECB speculation lift yields

2018-06-07 reuters
LONDON, June 7 (Reuters) - European shares switched to risk-on mode on Thursday, joining an overnight rally on Wall Street and in Asia, with the banking sector posting the best performance amid expectations that the European Central Bank may soon start to wind down its stimulus.
RCO REMYY REMYF

1
Carlsberg Loses Market Share in Russia on Beer Turmoil - Bloomberg

2018-05-01 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RCO REMYY RI REMYF

1
GRAPHIC-Euro's boom spells corporate gloom for region's exporters

2018-05-01 reuters
LONDON (Reuters) - A strong euro has helped U.S. companies extend their sales outperformance over Europe to multi-year highs in the first quarter, according to Reuters data - though experts expect the trend to begin to reverse later this year.
RCO REMYY RI REMYF

27
Tipsy Profits: Whiskey & Spirits ETF

2018-04-06 seekingalpha
Welcome to the first ETF to provide diversified exposure to the global whiskey and spirits industry.
532432 TWMJF BF.B DGEAF WEED UNITDSPR UQNTY MGPI RCO REMYY RI REMYF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:RCO / REMY COINTREAU on message board site Silicon Investor.

American Superconductor (AMSC) IntercontinentalExchange ICE
UTStarcom Inc. (UTSI) San Marco (SMN.V) Samples 8.46 g/t Gold; 43.0 g/t Silver; 1.
ROMARCO MINERALS - R : TSE Silvercorp Metals Inc.
Pen Intercom (PENC) - Ready to fly? New reconfigurable supercomputer that fits on your desktop
HURC Hurco coming on strong Conductus (NASDAQ: CDTS) superconductors